Determining the relationship between serum acute phase reactants and cervical premalignant lesions
Keywords:
Squamous ıntraepithelial lesions, Uterine cervical neoplasms, Albumins, Procalcitonin, FibrinogenAbstract
BACKGROUND: Acute phase reactants play a role in the progression and prognosis of many malignant and premalignant tumors. This study investigated the diagnostic value of certain reactants as markers for cervical premalignant lesions. OBJECTIVES: Despite advanced screening and vaccination programs, cervical cancer remains a serious health problem worldwide. We aimed to determine the possible relationship between premalignant cervical disease and serum acute phase reactant levels. DESIGN AND SETTING: This study included 124 volunteers who underwent cervical cancer screening. We divided the patients into three groups according to cervical cytology and histopathological findings as follows: no cervical lesion, low-grade neoplasia, or high-grade neoplasia. METHODS: We included women aged 25–65 years with benign smear or colposcopy results, low- and high-grade squamous intraepithelial lesions. The benign group was based only on cytology findings, whereas the other groups were based on histopathology findings. Demographic data and serum albumin, fibrinogen, ferritin, and procalcitonin levels were evaluated in the three groups. RESULTS: We found significant differences among the three groups in terms of age, albumin level, albumin/ fibrinogen ratio, and procalcitonin level. The regression analysis revealed lower serum albumin levels in the low- and high-grade squamous intraepithelial lesion groups compared with the benign group. CONCLUSION: This is the first study to evaluate the importance of serum inflammatory markers in cervical intraepithelial lesions. Our results indicate that serum albumin level, albumin/fibrinogen ratio, procalcitonin level, and neutrophil values differ among cervical intraepithelial lesions.
Downloads
References
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7-33. Erratum in: CA Cancer J Clin. 2021;71(4):359. PMID: 33433946; https://doi.org/10.3322/caac.21654.
Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-9. PMID: 10451482; https://doi.org/10.1002/(SICI)1096-9896(199909)189:1≤12::AID-PATH431≥3.0.CO;2-F.
Collins Y, Einstein MH, Gostout BS, et al. Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists. Gynecol Oncol. 2006;102(3):552-62. PMID: 16979432; https://doi.org/10.1016/j.ygyno.2006.07.022.
Sun DW, An L, Lv GY. Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: an updated meta-analysis. World J Surg Oncol. 2020;18(1):9. PMID: 31931816; http://doi.org/10.1186/s12957-020-1786-2.
Toriola AT, Grankvist K, Agborsangaya CB, et al. Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study. Ann Oncol. 2011;22(8):1916-21. PMID: 21292643; https://doi.org/10.1093/annonc/mdq694.
Acmaz G, Aksoy H, Unal D, et al. Are neutrophil/lymphocyte and platelet/lymphocyte ratios associated with endometrial precancerous and cancerous lesions in patients with abnormal uterine bleeding? Asian Pac J Cancer Prev. 2014;15(4):1689-92. PMID: 24641391; https://doi.org/10.7314/APJCP.2014.15.4.1689.
Wang X, An P, Zeng J, et al. Serum ferritin in combination with prostate-specific antigen improves predictive accuracy for prostate cancer. Oncotarget. 2017;8(11):17862-72. PMID: 28160568; https://doi.org/10.18632/oncotarget.14977.
Canat L, Atalay HA, Can O, Alkan İ, Ötünçtemur A. Serum procalcitonin levels in prostate cancer: A new biomarker? Urologia. 2018;85(2):46-50. PMID: 30043712; https://doi.org/10.1177/0391560317752600.
Huang L, Mo Z, Zhang L, et al. Diagnostic value of albumin to fibrinogen ratio in cervical Cancer. Int J Biol Markers. 2020;35(2):66-73. PMID: 32389031; https://doi.org/10.1177/1724600820915916.
Nayar R, Wilbur DC. The Pap Test and Bethesda 2014: “The reports of my demise have been greatly exaggerated. (after a quotation from Mark Twain)”. J Low Genit Tract Dis. 2015;19(3):175-84. PMID: 25943863; https://doi.org/10.1097/LGT.0000000000000115.
Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191-e203. PMID: 31812369, https://doi.org/10.1016/S2214-109X(19)30482-6.
Köse FM, Naki MM. Cervical premalignant lesions and their management. J Turk Ger Gynecol Assoc. 2014;15(2):109-21. PMID: 24976778; https://doi.org/10.5152/jtgga.2014.29795.
Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Williston Park). 2002;16(2):217-26, 229; discussion 230-2. PMID: 11866137.
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002 Dec19-26;420(6917):860-7. PMID: 12490959; https://doi.org/10.1038/nature01322.
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883-99. PMID: 20303878; https://doi.org/10.1016/j.cell.2010.01.025.
Sattar N, Scott HR, McMillan DC, et al. Acute-phase reactants and plasma trace element concentrations in non-small cell lung cancer patients and controls. 1997;28(3):308-12. PMID: 9343841; https://doi.org/10.1080/01635589709514592.
Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA. 2004;291(5):585-90. PMID: 14762037; https://doi.org/10.1001/jama.291.5.585.
Zhang Y, Xiao G. Prognostic significance of the ratio of fibrinogen and albumin in human malignancies: a meta-analysis. Cancer Manag Res. 2019;11:3381-93. PMID: 31114374; https://doi.org/10.2147/CMAR.S198419.
Tan Z, Zhang M, Han Q, et al. A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the fibrinogen/albumin ratio. J Cancer. 2017;8(6):1025-9. PMID: 28529615; https://doi.org/10.7150/jca.16491.
Sun SY, Chen PP, Meng LX, et al. High preoperative plasma fibrinogen and serum albumin score is associated with poor survival in operable esophageal squamous cell carcinoma. Dis Esophagus. 2019;32(1). PMID: 29905761; https://doi.org/10.1093/dote/doy057.
Li SQ, Jiang YH, Lin J, et al. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals. Cancer Med. 2018;7(4):1221-31. PMID: 29533009; https://doi.org/10.1002/cam4.1428.
Zhang X, Long Q. Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients. Medicine (Baltimore). 2017;96(17):e6694. PMID: 28445272; https://doi.org/10.1097/MD.0000000000006694.
Luo Y, Kim HS, Kim M, Lee M, Song YS. Elevated plasma fibrinogen levels and prognosis of epithelial ovarian cancer: a cohort study and meta-analysis. J Gynecol Oncol. 2017;28(3):e36. PMID: 28382799; https://doi.org/10.3802/jgo.2017.28.e36.
Sbrana A, Torchio M, Comolli G, et al. Use of procalcitonin in clinical oncology: a literature review. New Microbiol. 2016;39(3):174-80. PMID: 27284982.
Algeciras-Schimnich A, Preissner CM, Theobald JP, Finseth MS, Grebe SKG. Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. J Clin Endocrinol Metab. 2009;94(3):861-8. PMID: 19088163; https://doi.org/https://doi.org/10.1210/jc.2008-1862.
Avrillon V, Locatelli-Sanchez M, Folliet L, et al. Lung cancer may increase serum procalcitonin level. . Infect Disord Drug Targets. 2015;15(1):57-63. PMID: 25809625; https://doi.org/10.2174/1871526515666150320 162950.
Matzaraki V, Alexandraki KI, Venetsanou K, et al. Evaluation of serum procalcitonin and interleukin-6 levels as markers of liver metastasis. Clin Biochem. 2007;40(5-6):336-42. PMID: 17306245; https://doi.org/10.1016/j.clinbiochem.2006.10.027.
Zhang P, Zong Y, Liu M, et al. Prediction of outcome in breast cancer patients using test parameters from complete blood count. Mol Clin Oncol. 2016;4(6):918-24. PMID: 27284423; https://doi.org/10.3892/mco.2016.827.
Spell DW, Jones DV Jr, Harper WF, David Bessman J. The value of a complete blood count in predicting cancer of the colon. Cancer Detect Prev. 2004;28(1):37-42. PMID: 15041076; https://doi.org/10.1016/j.cdp.2003.10.002.
Arda E, Arikan G, Akdere H, Akgul M, Yuksel I. Predictive and prognostic impact of preoperative complete blood count based systemic inflammatory markers in testicular cancer. Int Braz J Urol. 2020;46(2):216-23. PMID: 32022510; https://doi.org/10.1590/S1677-5538.IBJU.2018.0820.
Tas M, Yavuz A, Ak M, Ozcelik B. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in discriminating precancerous pathologies from cervical cancer. J Oncol. 2019;2019:2476082. PMID: 31558903; https://doi.org/10.1155/2019/2476082.
Proctor MJ, McMillan DC, Morrison DS, et.al. A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer. 2012;107(4):695-9. PMID: 22828611; https://doi.org/10.1038/bjc.2012.292.
Komura N, Mabuchi S, Yokoi E, et al. Comparison of clinical utility between neutrophil count and neutrophil–lymphocyte ratio in patients with ovarian cancer: a single institutional experience and a literature review. Int J Clin Oncol. 2018;23(1):104-13. PMID: 28951992; https://doi.org/10.1007/s10147-017-1180-4.
